Get the Stockscreener App
0.8193
40.95%
0.2379
After Hours:
.78
-0.0393
-4.80%
Tenaya Therapeutics Inc stock is traded at $0.8193, with a volume of 31.40M.
It is up +40.95% in the last 24 hours and up +9.27% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$0.5814
Open:
$0.6276
24h Volume:
31.40M
Relative Volume:
6.07
Market Cap:
$177.38M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-0.6207
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
+34.54%
1M Performance:
+9.27%
6M Performance:
-39.30%
1Y Performance:
+80.11%
1-Day Range:
$0.6008
$0.82
1-Week Range:
$0.5316
$0.82
52-Week Range:
$0.36
$2.35
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.8193 | 125.88M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Tenaya Therapeutics Stock Jumps After New Alnylam Deal - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments - marketscreener.com
Tenaya Therapeutics Signs Potential $1.13 Billion Deal With Alnylam - marketscreener.com
Tenaya Therapeutics Announces Major Cardiovascular Gene Target Collaboration - TipRanks
Alnylam’s research pact worth up to $1.1B sends Tenaya higher - Seeking Alpha
Tenaya Therapeutics Enters into Research Collaboration with - GlobeNewswire
TNYA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TNYA SEC FilingsTenaya Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Update Report: Is Tenaya Therapeutics Inc in a long term uptrendJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026 - Bitget
Biotech Tenaya Therapeutics to stream CEO chat from Miami conference - Stock Titan
Tenaya Therapeutics (TNYA) Projected to Post Earnings on Monday - MarketBeat
Tenaya Therapeutics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Group Gp Lp Column III Sells 3,511,826 Shares of Tenaya Therapeutics (NASDAQ:TNYA) Stock - MarketBeat
Insider Selling: Tenaya Therapeutics (NASDAQ:TNYA) Major Shareholder Sells 658,440 Shares of Stock - MarketBeat
Venture firm Column Group (TNYA) details 23.1% Tenaya stake and stock sales - Stock Titan
Column Group funds trim Tenaya (TNYA) stake with 4.17M-share sale - Stock Titan
[144] Tenaya Therapeutics, Inc. SEC Filing - Stock Titan
Column Group files Form 144 for Tenaya Therapeutics (NASDAQ: TNYA) with share sale rows - Stock Titan
Major Tenaya Therapeutics Shareholder Makes Bold Move With Large Stock Sale - TipRanks
Column Group funds trim Tenaya Therapeutics (TNYA) with 829,734-share sale - Stock Titan
TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Tenaya Therapeutics (NASDAQ: TNYA) insider sells 1.905M and 161k shares - Stock Titan
Column Group III‑A sells large TNYA stake (02/2026) — TNYA - Stock Titan
What margin trends mean for Tenaya Therapeutics Inc. stockWall Street Watch & Entry Point Confirmation Alerts - mfd.ru
How Tenaya Therapeutics Inc. stock benefits from tech adoptionAnalyst Upgrade & Fast Moving Stock Watchlists - mfd.ru
Why Tenaya Therapeutics Inc. stock is favored by pension fundsShort Setup & Risk Controlled Daily Plans - mfd.ru
Bull Run: Is Tenaya Therapeutics Inc a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Form 4: Ali Faraz reports sale transactions in TNYA - Stock Titan
Planned sale of 5,160 TNYA shares disclosed in Rule 144 notice - Stock Titan
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Tenaya Therapeutics Inc. stock recession proofMarket Activity Recap & Fast Moving Stock Trade Plans - mfd.ru
TNYA PE Ratio & Valuation, Is TNYA Overvalued - Intellectia AI
Tenaya Therapeutics Inc. (TNYA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Insider Selling: Tenaya Therapeutics (NASDAQ:TNYA) Major Shareholder Sells 4,056,573 Shares of Stock - MarketBeat
Group Gp Lp Column III Sells 343,717 Shares of Tenaya Therapeutics (NASDAQ:TNYA) Stock - MarketBeat
Can Tenaya Therapeutics Inc generate free cash flowJuly 2025 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn
Is Tenaya Therapeutics Inc. stock influenced by commodity pricesWeekly Profit Recap & Capital Efficient Trading Techniques - mfd.ru
Investment Review: Is Tenaya Therapeutics Inc. stock a safe buy before earningsDividend Hike & Trade Opportunity Analysis - mfd.ru
Tenaya Therapeutics (TNYA) holder files to sell 1,408,910 Rule 144 shares - Stock Titan
Breakouts Watch: Is Tenaya Therapeutics Inc a speculative investmentJuly 2025 Selloffs & Safe Entry Point Alerts - baoquankhu1.vn
Why retail investors favor Tenaya Therapeutics Inc. stockWeekly Trade Analysis & Weekly High Return Forecasts - mfd.ru
Tenaya Therapeutics receives Nasdaq notice on minimum bid price and amends equity plan By Investing.com - Investing.com South Africa
Tenaya Therapeutics receives Nasdaq notice on minimum bid price and amends equity plan - Investing.com Nigeria
Guidance Update: Is Waton Financial Limited stock a good pick for beginnersGap Down & Consistent Return Investment Signals - baoquankhu1.vn
Tenaya Therapeutics Faces Nasdaq Deficiency, Amends Equity Plan - TipRanks
Tenaya Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq bid-price warning hits Tenaya Therapeutics (Nasdaq: TNYA) as equity inducement pool grows - Stock Titan
Update Report: Is Tenaya Therapeutics Inc a speculative investmentJuly 2025 Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Is Tenaya Therapeutics Inc. part of any ETF2025 Support & Resistance & Stepwise Swing Trade Plans - mfd.ru
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):